echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Viagra's "cousin" reduces obesity by stimulating cells to burn fat?

    Viagra's "cousin" reduces obesity by stimulating cells to burn fat?

    • Last Update: 2021-10-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    These findings, published in the Journal of Clinical Investigation on October 7, revealed that a chemical inhibitor of the PDE9 enzyme stimulates cells to burn more fat


    Inhibition of PDE9 did not cause these changes in female mice with ovaries, so the status of female sex hormones is important in this study


    "Currently, there are no drugs that have been proven effective in treating severe obesity.


    Prior to this study, a research report published by the laboratory in 2015 showed for the first time that the PDE9 enzyme is present in the heart and causes heart disease caused by high blood pressure


    Based on these results, researchers suspect that PDE9 inhibition may improve Cardiometabolic Syndrome (CMS), a common disease including high blood pressure; high blood sugar, cholesterol and triglycerides; excessive body fat, especially in the waist


    Although PDE9 inhibitors are still in the experimental stage, several pharmaceutical companies have developed them and tested their efficacy against diseases such as Alzheimer's disease and sickle cell disease in humans


    To test the effects of PDE9 inhibitors on obesity and cardiometabolic syndrome, the researchers asked mice to eat high-fat foods.


    In female mice without ovaries (a postmenopausal model), the median percentage difference in weight change between the drug group and the placebo group was -27.


    Researchers have found that PDE9 inhibition produces these effects by activating PPARa, the main regulator of fat metabolism


    Researcher Sumita Mishra pointed out: "This experimental drug is not good for female mice.


    According to the US Centers for Disease Control and Prevention (US Centers for Disease Control and Prevention), more than 40% of Americans are obese; 43% of American women over the age of 60 — who have passed menopause long ago — are considered obese


    Cass pointed out that if his laboratory findings on mice are applicable to humans, a 250-pound person can lose about 50 pounds by oral PDE9 inhibitors without changing their diet or exercise habits


    "I am not suggesting to take a pill like a TV fan, but I suspect that combined with diet and exercise, the effect of PDE9 inhibition may be greater


    "PDE9 inhibitors have been studied in humans, so clinical obesity research should not be far away from us


    Journal Reference :

    1. Sumita Mishra, Nandhini Sadagopan, Brittany Dunkerly-Eyring, Susana Rodriguez, Dylan C.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.